Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019028980) ANTI-HUMAN PAPILLOMA VIRUS AND ANTI-CD HUMANISED DUAL TARGETING ANTIBODY, AND COMPOSITION, PREPARATION METHOD, AND APPLICATION THEREOF
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/028980 International Application No.: PCT/CN2017/103683
Publication Date: 14.02.2019 International Filing Date: 27.09.2017
IPC:
C07K 16/46 (2006.01) ,C07K 1/14 (2006.01) ,A61K 39/42 (2006.01) ,A61P 31/20 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
46
Hybrid immunoglobulins
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
1
General processes for the preparation of peptides
14
Extraction; Separation; Purification
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
395
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
42
viral
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12
Antivirals
20
for DNA viruses
Applicants:
深圳市雅臣智能生物工程有限公司 SHENZHEN JASON INTELLIGENT BIOTECHNOLOGY COMPANY LIMLTED. PRC [CN/CN]; 中国广东省深圳市 龙华新区清祥路一号宝能科技园9栋C座1306室 Room 1306 Bldg 9C Baoneng Science and Technology Park Shenzhen, Guangdong 518109, CN
Inventors:
包晟 BAO, Sheng; CN
杨荣鉴 YANG, Rongjian; CN
谢亦武 XIE, Yiwu; CN
曹天福 CAO, Tianfu; CN
龚芹 GONG, Qin; CN
Agent:
深圳市顺天达专利商标代理有限公司 SHENZHEN STANDARD PATENT & TRADEMARK AGENT LTD.; 中国广东省深圳市 福田区深南大道1056号银座国际大厦810-815室 Room 810-815 Yinzuo International Building No.1056 Shennan Boulevard, Futian District Shenzhen, Guangdong 518040, CN
Priority Data:
201710680536.610.08.2017CN
Title (EN) ANTI-HUMAN PAPILLOMA VIRUS AND ANTI-CD HUMANISED DUAL TARGETING ANTIBODY, AND COMPOSITION, PREPARATION METHOD, AND APPLICATION THEREOF
(FR) ANTICORPS À CIBLAGE DOUBLE ANTI-PAPILLOMAVIRUS HUMAIN ET ANTI-CD HUMANISÉ, COMPOSITION, PROCÉDÉ DE PRÉPARATION ET APPLICATION DE CELUI-CI
(ZH) 抗人乳头瘤病毒和抗CD人源化的双靶向抗体及其组合物、制备方法和应用
Abstract:
(EN) Provided in the present invention are an anti-human papilloma virus and anti-CD humanised dual targeting antibody, and a composition, a preparation method, and an application thereof, the antibody comprising a murine-human chimeric antibody light chain full-length gene sequence and murine-human chimeric antibody heavy chain full-length gene sequence cloned on vectors, the vectors comprising viral gene vectors and non-viral gene vectors, the murine-human chimeric light chain full-length gene sequence and heavy chain full-length gene sequence respectively being obtained by sequencing an antibody light chain and heavy chain obtained through immunisation of related antigens.
(FR) La présente invention concerne un anticorps à ciblage double anti-papillomavirus humain et anti-CD humanisé, et une composition, un procédé de préparation et une application de celui-ci, l'anticorps comprenant une séquence génique pleine longueur de chaîne légère d'anticorps chimérique humain-murin et une séquence génique pleine longueur de chaîne lourde d'anticorps chimérique humain-murin clonées sur des vecteurs, les vecteurs comprenant des vecteurs de gènes viraux et des vecteurs de gènes non viraux, la séquence génique pleine longueur de chaîne légère chimérique humain-murin et la séquence génique pleine longueur de chaîne lourde étant respectivement obtenues par séquençage d'une chaîne légère d'anticorps et d'une chaîne lourde obtenue par immunisation d'antigènes apparentés.
(ZH) 本发明提供了一种抗人乳头瘤病毒和抗CD人源化的双靶向抗体及其组合物、制备方法和应用,所述抗体包括克隆于载体的鼠-人嵌合抗体轻链全长基因序列和鼠-人嵌合抗体重链全长基因序列,所述载体包括病毒类基因载体和非病毒基因载体,所述鼠-人嵌合抗体轻链全长基因序列和重链全长基因分别通过相关抗原免疫后得到的抗体轻链和重链测序得到。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)